Clinical Drug Experience Knowledgebase

aluminum hydroxide (Gaviscon) (2 trials)

alvac-hiv vaccine (2 trials)

bacille calmette-guerin (1 trial)

bivalent subtype c gp120 (2 trials)

desflurane (suprane) (2 trials)

hiv-1 dna plasmid vaccine (1 trial)

mf59 (1 trial)

mrkad5 hiv-1 gag/pol/nef (2 trials)

mtbvac (1 trial)

recombinant adenoviral serotype 5 vector vaccine (1 trial)

trivalent mrkad5 hiv-1 gag/pol/nef (1 trial)

vcp1521 (2 trials)

vrchivadv014-00-vp (2 trials)

vrc-hivdna-016-00-vp (1 trial)

3m-052-af (2 trials)

ad26.enva.01 vaccine (1 trial)

ad35-env (1 trial)

adc6-hivgp140 (1 trial)

adc7-hivgp140 (1 trial)

aidsvax b/e (3 trials)

aluminum (1 trial)

avx101 (2 trials)

bg505 sosip.664 gp140 (1 trial)

ch505tf gp120 (2 trials)

cpg 1018 (1 trial)

dna-c2 (1 trial)

dna con-s env (2 trials)

dna-hiv-pt123 (3 trials)

dna mosaic env (2 trials)

dna nat-b env (2 trials)

ep-1233 (1 trial)

gla-lsq (1 trial)

gla-se (2 trials)

glycoprotein 140 (1 trial)

h4 (1 trial)

ic31 (1 trial)

il-12 dna (1 trial)

interleukin-12 (1 trial)

interleukin-15 (1 trial)

mva-c (1 trial)

mva-cmdr (1 trial)

mva-hiv62 (1 trial)

mva-mbn32 (1 trial)

nyvac-b (1 trial)

nyvac con-s env vaccine (1 trial)

nyvac-hiv-pt1 (2 trials)

nyvac-hiv-pt4 (2 trials)

nyvac mosaic env vaccine (1 trial)

nyvac nat-b env vaccine (1 trial)

pennvax-b (1 trial)

pga2/js7 (1 trial)

pgdm1400 (1 trial)

pgt121 (2 trials)

protein/mf59 (1 trial)

rad35 (1 trial)

rad5 (2 trials)

saavi dna-c2 vaccine (1 trial)

saavi mva-c vaccine (1 trial)

sd-np-gt8 (1 trial)

trimer 4571 (1 trial)

v520 (1 trial)

vir-1388 (1 trial)

vrc01.23ls (1 trial)

vrc07-523ls (1 trial)

vrc-hivadv027-00-vp (1 trial)

vrc-hivadv038-00-vp (1 trial)

vrc-hivdna009-00-vp (1 trial)

vrc-hivdna044-00-vp (1 trial)